Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: A prospective study

Annals of Surgery

Volumn 254, Issue 4, 2011, Pages 569-576

  Fan, Sheung Tat ^a   Yang, Zhen Fan ^a,b   Ho, David W Y ^a   Ng, Michael N P ^a   Yu, Wan Ching ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURVIVAL; CELL ISOLATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 80053284820     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182300a1d     Document Type: Conference Paper

References (37)

1. Fan ST, Lo CM, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011;253:745-758.
2. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol. 2009;6:339-351.
3. Lemoine A, Le Bricon T, Salvucci M, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg. 1997;226:43-50. (Pubitemid 27468902)
4. Funaki NO, Tanaka J, Seto SI, et al. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology. 1997;25:564-568. (Pubitemid 27106434)
5. Okuda N, Nakao A, Takeda S, et al. Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC. Hepatogastroenterol- ogy. 1999;46:381-386. (Pubitemid 29154781)
6. Witzigmann H, Geissler F, Benedix F, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery. 2002;131:34-43. (Pubitemid 34118594)
7. Ijichi M, Takayama T, Matsumura M, et al. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology. 2002;35:853-860. (Pubitemid 34258379)
8. Gross-Goupil M, Saffroy R, Azoulay D, et al. Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg. 2003;238:241-248. (Pubitemid 38174499)
9. Kong SY, Park JW, Kim JO, et al. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepa-tocellular carcinoma. J Cancer Res Clin Oncol. 2009;135:1091-1098.
10. Yao F, Guo JM, Xu CF, et al. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Clin Chim Acta. 2005;361:119-127. (Pubitemid 41382614)
11. Wong IH, Lau WY, Leung T, et al. Hematogenous dissemination of hepato-cytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999;5:4021-4027. (Pubitemid 30013779)
12. Kamiyama T, Takahashi M, Nakagawa T, et al. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg. 2006;244:451-463.
13. Morimoto O, Nagano H, Miyamoto A, et al. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood. Surg Today. 2005;35:1033-1041. (Pubitemid 41772299)
14. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology. 1995;21: 403-407.
15. Gion T, Taketomi A, Shimada M, et al. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology. 1998;28:1663-1668. (Pubitemid 28549138)
16. Müller C, Petermann D, Pfeffel F, et al. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells. Hepatology. 1997;25:896-899. (Pubitemid 27157131)
17. Cheung ST, Fan ST, Lee YT, et al. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma. Transplantation. 2008;85:81-87.
18. Qian J, Yao D, Dong Z, et al. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma. Am J Clin Pathol. 2010;134:799-806.
19. Min AL, Choi JY, Woo HY, et al. High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin Exp Metastasis. 2009;26:759-767.
20. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111. (Pubitemid 33041634)
21. Yang ZF, Ho DW, Ng MN, et al. Significance of CD90 + cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153-166. (Pubitemid 351163165)
22. Yang ZF, Ngai P, Ho DW, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology. 2008;47:919-928. (Pubitemid 351449683)
23. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg. 1999;16:459-467. (Pubitemid 30072153)
24. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
25. Sobin LH, Whitekind CH. TNM Classification of Malignant Tumors. 5th ed. New York, NY: John Wiley; 1997.
26. Chun JM, Kwon HJ, Sohn J, et al. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol. 2011;103:148-151.
27. Li B, Yuan Y, Chen G, et al. Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome? BMC Cancer. 2010;10:535.
28. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704-715. (Pubitemid 351636299)
29. Bidard FC, Vincent-Salomon A, Gomme S, et al. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Clin Cancer Res. 2008;14:3306-3311.
30. Meng S, Tripathy D, Frenkel EP, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004;10:8152-8162. (Pubitemid 40053373)
31. Méhes G, Witt A, Kubista E, et al. Circulating breast cancer cells are frequently apoptotic. Am J Pathol. 2001;159:17-20. (Pubitemid 33704186)
32. Hung IF, Poon RT, Lai CL, et al. Recurrence of hepatitis B-related hepatocel-lular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol. 2008;103:1663-1673.
33. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867. (Pubitemid 36019639)
34. Chok KS, Ng KK, Poon RT, et al. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg. 2009;96:81-87.
35. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834-846. (Pubitemid 350006258)
36. Cucchetti A, Piscaglia F, Caturelli E, et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2009;16:413-422.
37. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-390